Carregant...
Effects of Abaloparatide-SC on Bone Mineral Density and Risk of Fracture in Postmenopausal Women Aged 80 Years or Older with Osteoporosis
OBJECTIVE: Advanced age is an important risk factor for fracture. The ACTIVE (Abaloparatide Comparator Trial In Vertebral Endpoints) trial showed that abaloparatide-SC increased bone mineral density and reduced the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosi...
Guardat en:
| Publicat a: | Menopause |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6015760/ https://ncbi.nlm.nih.gov/pubmed/29462094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001080 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|